Protecting Primary Cell Viability: Essential Cryopreservation and Handling Strategies

Human primary cells are widely used in drug discovery, disease modeling, and regenerative medicine because they more closely reflect human biology than immortalized cell lines. However, primary cells have a finite lifespan in culture and can lose functionality over time. To preserve these valuable biological resources, researchers rely on cryopreservation for long-term storage and future use. By storing cells at ultra-low temperatures, typically below -135°C in liquid nitrogen vapor, cryopreservation effectively halts cellular activity and helps maintain cell viability and function over extended periods^1-3.

Cryopreservation Challenges

Primary cells are inherently fragile and more sensitive to environmental stress than immortalized cell lines. As a result, the primary goal of cryopreservation is to protect cells from damage as they transition to lower temperatures to a frozen state. One of the greatest challenges during freezing is preventing cryoinjury caused by intracellular ice formation.

As temperatures fall below freezing, ice begins to form in the extracellular environment, increasing the concentration of dissolved solutes surrounding the cell. This creates an osmotic gradient that draws water out of the cell. If cooling occurs too rapidly, insufficient water leaves the cell before freezing, resulting in the formation of intracellular ice crystals^1-3. These crystals can physically disrupt cellular membranes, organelles, and cytoskeletal structures, leading to irreversible damage and cell death upon thawing.

To minimize these effects, cells are suspended in cryopreservation media containing cryoprotective agents (CPAs), such as dimethyl sulfoxide (DMSO) or glycerol, which help reduce ice crystal formation and protect cellular structures during freezing. Cells are then cooled at a controlled rate, typically around -1°C per minute for mammalian cells, allowing water to leave the cell gradually and reducing the likelihood of intracellular ice formation⁴. Once frozen, cells are transferred to liquid nitrogen vapor for long-term storage at temperatures below -150°C.

The success of cryopreservation depends on multiple factors, including the choice of cryopreservation medium, cooling rate, freezing equipment, and importantly, the cell type. Not every cryopreservation strategy works for all primary cells; therefore, optimization is critical for maximizing post-thaw recovery and performance. Lifeline® Cell Technology has developed cell type-specific cryopreservation protocols for primary keratinocytes, fibroblasts, stem cells, and other cell types to help ensure high viability, recovery, and functionality post-thaw.

The Hidden Risk of Transient Temperature Fluctuations

Even when cells are cryopreserved using validated protocols, sample quality can deteriorate if proper handling practices are not maintained throughout storage and recovery. Brief temperature fluctuations during routine handling can negatively impact cell viability and function, even when samples never visibly thaw^5,6.

Cryovials removed from liquid nitrogen storage begin warming immediately. For example, vials may be exposed to ambient temperatures during inventory management, sample retrieval, or transfer between storage locations. Similarly, holding a cryovial in an unprotected gloved hand for as little as 15 to 30 seconds can raise the temperature sufficiently to trigger localized warming. If these samples are subsequently returned to dry ice or liquid nitrogen storage, the resulting ice recrystallization can damage cellular structures and reduce post-thaw viability and recovery^5,6.

Because these transient warming events can commonly occur during routine laboratory workflows, maintaining proper cryogenic handling procedures is just as important as the initial cryopreservation process itself.

Best Practices for Handling Cryopreserved Cells

Following these practices helps minimize temperature excursions when transferring cryopreserved cells from a shipping container to long-term storage:

1. Wear appropriate personal protective equipment (PPE), including safety glasses and cryogenic gloves, before handling any frozen samples.
2. Use forceps to handle vials, as direct contact with warm fingers can rapidly transfer heat to the cryovial and initiate localized warming.
3. Ensure that storage boxes, canes, or racks are properly labeled and pre-chilled (if new) before removing samples from the shipping container.
4. If storage boxes or canes must be removed from liquid nitrogen, place them on dry ice or maintain them within the cold zone of the storage system whenever possible.
5. Use a container of dry ice as a temporary working station for holding the box or cane while vials are being transferred.

1. 1. Alternatively, a foam container containing an absorbent pad saturated with liquid nitrogen can be used to maintain a cold working environment.

6. Once the receiving box or cane has been prepared, work quickly to transfer vials from the shipping container using forceps directly into their designated storage location.
7. After placement into the receiving box or cane, promptly return vials to liquid nitrogen vapor storage or an appropriate ultra-low temperature freezer.

The same principles apply when retrieving cryopreserved cells for experimental use. Before accessing storage, prepare a dry ice container to receive vials. Retrieve samples using forceps and immediately transfer them to dry ice. Keep vials on dry ice and avoid unnecessary handling  until ready to thaw cells.

Best Practices for Thawing Cryopreserved Primary Cells

Just as improper handling can damage cryopreserved cells before use, the thawing process can significantly influence post-thaw viability and recovery. During thawing, cells experience a rapid temperature shift, osmotic changes, and exposure to residual cryoprotective agents such as dimethyl sulfoxide (DMSO), which can become cytotoxic if not promptly diluted and removed. For this reason, cells should be transitioned quickly and carefully into appropriate culture conditions.

Following these practices for thawing cells helps minimize cellular stress:

1. Only place the cryovial into a 37°C water bath when you are ready to proceed immediately through to plating.

1. 1. Prepare pre-warmed culture media and appropriately labeled culture vessels in advance.

2. Limit thawing time in the water bath to no more than 2 minutes.
3. Immediately dry the exterior of the vial after removal from the water bath. Residual water bath fluid may contain microbial contaminants despite chemical treatment.
4. Spray the vial with 70% isopropanol and transfer it into a biosafety cabinet. Allow the exterior to fully dry or carefully remove excess disinfectant before opening the vial, as even tiny amounts of residual alcohol can negatively affect cell viability.
5. It is highly recommended to perform a cell count and viability assessment following thaw. This step confirms cells are viable and suitable for downstream applications. Instructions are included in Lifeline’s cell instruction sheets.
6. Plate or inoculate cells at the recommended density in pre-warmed media according to the cell type-specific protocol.

As part of routine quality control, each lot of Lifeline’s cryopreserved primary cells is evaluated for post-thaw performance. This includes thawing representative vials and performing viable cell counts to confirm that cells meet established post-thaw viability acceptance criteria following cryopreservation and thawing procedures.

Conclusions

Maintaining cell viability and functional integrity of primary cells during and after cryopreservation requires attention to detail at every stage of the workflow, as even brief deviations from optimal conditions from sample handling can have lasting effects on post-thaw performance. Utilizing best practices consistently is therefore essential to preserving the biological relevance of primary cells and ensuring reliable experimental outcomes.

If you have any questions about Lifeline primary cells, please contact us: https://www.lifelinecelltech.com/contact-us/

References

1. Hussein M. Cryopreservation and Recovery of Primary Cells: Best Practices and Pitfalls. Cell Culture Technologies – Primary Cell Isolation, Growth and Analysis [Working Title]. Published online July 11, 2025. doi:https://doi.org/10.5772/intechopen.1011569
2. Whaley D, Damyar K, Witek RP, Mendoza A, Alexander M, Lakey JR. Cryopreservation: An Overview of Principles and Cell-Specific Considerations. Cell Transplant. 2021;30:963689721999617. doi:10.1177/0963689721999617
3. Bojic S, Murray A, Bentley BL, et al. Winter is coming: the future of cryopreservation. BMC Biol. 2021;19(1):56. Published 2021 Mar 24. doi:10.1186/s12915-021-00976-8
4. Awan M, Buriak I, Fleck R, et al. Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?. Regen Med.2020;15(3):1463-1491. doi:10.2217/rme-2019-0145
5. Germann A, Oh YJ, Schmidt T, Schön U, Zimmermann H, von Briesen H. Temperature fluctuations during deep temperature cryopreservation reduce PBMC recovery, viability, and T-cell function. Cryobiology. 2013;67(2):193-200. doi:https://doi.org/10.1016/j.cryobiol.2013.06.012
6. Xu Y, Leo Li-Ying Chan, Chen S, et al. Optimization of UC-MSCs cold-chain storage by minimizing temperature fluctuations using an automatic cryopreservation system. Cryobiology. 2021;99:131-139. doi:https://doi.org/10.1016/j.cryobiol.2020.11.010